Figure 6.
Figure 6. Expression of TEL/PDGFβR augments IL-3–induced signaling cascades. BaF/3 clone TP2 was incubated in the presence (+ Tet) or absence (– Tet) of 2 μg/mL Tet for 24 hours. Cells were washed free of IL-3 and serum and incubated in serum-free media for 1 hour prior to being stimulated for the indicated period of time (in minutes) with 10 ng/mL rmIL-3 or left untreated (0). Whole cell lysates were prepared and 20 or 40 μg protein/sample was immunoblotted (IB) with the following antibodies: (A) Upper panel, 4G10 specific for tyrosine-phosphorylated proteins and in the lower panel anti-PDGFβR. (B) Antiphospho Ser473 of PKB (pPKB, upper panel); this blot was stripped and reprobed with a pan-PKB antibody (PKB, lower panel). (C) Antibody specific for phosphotyrosine 694/699 of STAT5a/b (pSTAT5, upper panel); this immunoblot was stripped and reprobed with an anti-STAT5 antibody to assess loading (STAT5, lower panel). (D) An antibody specific for dually phosphorylated ERK 1 and 2 (pERK1/2, upper panel); this blot was stripped and reprobed with an anti-panErk antibody (ERK, lower panel). (E) An antibody specific for dually phosphorylated p38 MAPK (pp38); this blot was stripped and reprobed with an anti-panp38 antibody (p38, lower panel). (F) An antibody specific for dually phosphorylated JNK1 and 2 (pJNK); this blot was stripped and reprobed with an anti-panJNK antibody (JNK2, lower panel). Positions of the phosphorylated and nonphosphorylated proteins are indicated, as are the molecular weight standards, in kilodaltons.

Expression of TEL/PDGFβR augments IL-3–induced signaling cascades. BaF/3 clone TP2 was incubated in the presence (+ Tet) or absence (– Tet) of 2 μg/mL Tet for 24 hours. Cells were washed free of IL-3 and serum and incubated in serum-free media for 1 hour prior to being stimulated for the indicated period of time (in minutes) with 10 ng/mL rmIL-3 or left untreated (0). Whole cell lysates were prepared and 20 or 40 μg protein/sample was immunoblotted (IB) with the following antibodies: (A) Upper panel, 4G10 specific for tyrosine-phosphorylated proteins and in the lower panel anti-PDGFβR. (B) Antiphospho Ser473 of PKB (pPKB, upper panel); this blot was stripped and reprobed with a pan-PKB antibody (PKB, lower panel). (C) Antibody specific for phosphotyrosine 694/699 of STAT5a/b (pSTAT5, upper panel); this immunoblot was stripped and reprobed with an anti-STAT5 antibody to assess loading (STAT5, lower panel). (D) An antibody specific for dually phosphorylated ERK 1 and 2 (pERK1/2, upper panel); this blot was stripped and reprobed with an anti-panErk antibody (ERK, lower panel). (E) An antibody specific for dually phosphorylated p38 MAPK (pp38); this blot was stripped and reprobed with an anti-panp38 antibody (p38, lower panel). (F) An antibody specific for dually phosphorylated JNK1 and 2 (pJNK); this blot was stripped and reprobed with an anti-panJNK antibody (JNK2, lower panel). Positions of the phosphorylated and nonphosphorylated proteins are indicated, as are the molecular weight standards, in kilodaltons.

Close Modal

or Create an Account

Close Modal
Close Modal